Mercator MedSystems

Mercator MedSystems is a private, clinical-stage medical device company pioneering targeted micro-infusion for vascular interventions. Founded in 2001 and based in San Leandro, California, the company's FDA-cleared Bullfrog device enables the localized delivery of drugs and biologics directly through vessel walls. Its lead clinical programs, the DEXTERITY trials in DVT and the TANGO trial in PAD, aim to address significant unmet needs by reducing chronic complications like post-thrombotic syndrome. The company is led by its inventor-founder, Dr. Kirk Seward, and is positioned in the growing field of interventional drug-device combination therapies.

Catheter-based micro-infusion system (Bullfrog® Device) for targeted, perivascular delivery of liquid therapeutics across vessel walls.

Competes indirectly with systemic pharmaceuticals and other local delivery devices like drug-coated balloons and stents. Its primary competition is the current standard of care (anticoagulation for DVT, plain angioplasty for PAD), as micro-infusion for perivascular steroid delivery is a novel approach without direct equivalents.